文献速递临床生化临床免疫质量管理与危急值

M蛋白对实验室诊断的干扰:机制与管理策略综述

M-protein interference in laboratory diagnostics: a comprehensive narrative review of mechanisms and management strategies.
PubMed 文献 · Clin Chem Lab Med · 2026-05-11

本文为叙述性综述,阐述单克隆蛋白(M蛋白)因物理沉淀、化学结合及免疫钩状效应等机制干扰凝血、临床化学与免疫检测,并涉及治疗性单克隆抗体产生的药物峰。文章汇总近期临床队列与技术评估证据,评价聚乙二醇沉淀、质谱与人工智能算法等识别与消除干扰的策略。

要点

  • M蛋白可干扰凝血、临床化学和免疫检测,导致错误结果。
  • 治疗性单克隆抗体可产生类似M蛋白的药物峰,混淆疗效评估。
  • 质谱与人工智能算法是新一代识别和消除干扰的策略。

核心结论

  • M蛋白干扰广泛影响凝血、临床化学和免疫检测平台,可根本性误导临床决策。

研究设计与样本

  • 叙述性综述,综合近期临床队列与技术评估证据,未报告系统检索范围与样本量。

主要发现

  • M蛋白的物理沉淀、化学结合与免疫钩状效应等机制导致分析伪影。
  • 治疗性单克隆抗体产生外源性药物峰,可模拟疾病标志物并掩盖治疗反应评估。

临床怎么用

  • 文章建立识别与解决M蛋白干扰伪影的综合框架,帮助临床与实验室人员保障患者安全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Monoclonal proteins (M-proteins) serve as critical biomarkers for plasma cell dyscrasias, yet their unique physicochemical properties paradoxically compromise the accuracy of routine laboratory diagnostics. Beyond causing well-documented anomalies in electrophoresis, M-protein interference pervasively affects coagulation, clinical chemistry, and immunoassay platforms, creating analytical artifacts that can fundamentally mislead clinical decision-making. The diagnostic landscape is further complicated by the widespread adoption of therapeutic monoclonal antibodies (t-mAbs), which introduce exogenous "drug spikes" mimicking disease markers and obscuring therapeutic response assessment. This narrative review elucidates the underlying mechanisms of these interferences, ranging from physical precipitation and chemical binding to immunological hook effects, and synthesizes evidence from recent clinical cohorts and technical evaluations. We critically assess the efficacy of mitigation strategies, highlighting the evolution from traditional techniques like polyethylene glycol precipitation to next-generation solutions involving mass spectrometry and artificial intelligence-driven algorithms. By establishing a comprehensive framework for the recognition and resolution of these artifacts, this article aims to equip clinicians and laboratorians with the tools necessary to ensure that laboratory diagnostics remain a pillar of patient safety.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Liang S, Wang X, Peng L, et al. M-protein interference in laboratory diagnostics: a comprehensive narrative review of mechanisms and management strategies. Clin Chem Lab Med. 2026. PMID: 42112830. doi:10.1515/cclm-2026-0118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。